title: Prevalence of disease and relationships between laboratory phenotype and bleeding severity in platelet primary secretion defects.
abstract: BACKGROUND
  The prevalence of platelet primary secretion defects (PSD) among patients with bleeding diathesis is unknown. Moreover, there is paucity of data on the determinants of bleeding severity in PSD patients.
  
  
  OBJECTIVE
  To determine the prevalence of PSD in patients with clinical bleeding and to study the relationships between the type of platelet defect and bleeding severity.
  
  
  METHODS
  Data on patients referred for bleeding to the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan (Italy) in the years between 2008 and 2012 were retrieved to study the prevalence of PSD. Demographic, clinical and laboratory information on 32 patients with a diagnosis of PSD was used to compare patients with or without associated medical conditions and to investigate whether or not the type and extension of platelet defects were associated with the bleeding severity score (crude and age-normalized) or with the age at first bleeding requiring medical attention.
  
  
  RESULTS
  The estimated prevalence of PSD among 207 patients with bleeding diathesis and bleeding severity score above 4 was 18.8% (95% confidence interval [CI]: 14.1-24.7%). Patients without associated medical conditions had earlier age of first bleeding (18 vs 45 years; difference: -27 years; 95% CI: -46 to -9 years) and different platelet functional defect patterns (Fisher's exact test of the distribution of patterns, P = 0.007) than patients with accompanying medical conditions. The type and extension of platelet defect was not associated with the severity of bleeding.
  
  
  CONCLUSIONS
  PSD is found in approximately one fifth of patients with clinical bleeding. In patients with PSD, the type and extension of laboratory defect was not associated with bleeding severity.
authors.affiliation: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Ca' Granda-Ospedale Maggiore Policlinico, Università degli Studi di Milano and Fondazione Luigi Villa, Milan, Italy.
authors.forename: Luca A
authors.initials: LA
authors.lastname: Lotta
authors.forename: Alberto
authors.initials: A
authors.lastname: Maino
authors.forename: Giacomo
authors.initials: G
authors.lastname: Tuana
authors.forename: Raffaella
authors.initials: R
authors.lastname: Rossio
authors.forename: Anna
authors.initials: A
authors.lastname: Lecchi
authors.forename: Andrea
authors.initials: A
authors.lastname: Artoni
authors.forename: Flora
authors.initials: F
authors.lastname: Peyvandi
mesh_terms: D000293:Adolescent; D000328:Adult; D001791:Blood Platelet Disorders / Q000453:epidemiology* / Q000473:pathology*; D005260:Female; D006470:Hemorrhage / Q000453:epidemiology* / Q000473:pathology*; D006801:Humans; D008297:Male; D015995:Prevalence; D055815:Young Adult
references.citation: J Thromb Haemost. 2011 Jul;9 Suppl 1:76-91
references.pmid: 21781244
references.citation: Blood Rev. 2011 Jul;25(4):169-73
references.pmid: 21497967
references.citation: Scand J Haematol. 1986 Jan;36(1):44-54
references.pmid: 3081995
references.citation: J Thromb Haemost. 2011 Jun;9(6):1143-8
references.pmid: 21435168
references.citation: J Thromb Haemost. 2006 Apr;4(4):766-73
references.pmid: 16634745
references.citation: Br Med J (Clin Res Ed). 1987 Sep 5;295(6598):581
references.pmid: 3117241
references.citation: Semin Thromb Hemost. 2009 Mar;35(2):158-67
references.pmid: 19408189
references.citation: J Thromb Haemost. 2011 Sep;9(9):1744-51
references.pmid: 21726405
references.citation: J Thromb Haemost. 2006 Oct;4(10):2164-9
references.pmid: 16999850
references.citation: Haematologica. 2007 Mar;92(3):357-65
references.pmid: 17339185
references.citation: Platelets. 2012;23(7):552-63
references.pmid: 23020613
references.citation: J Clin Invest. 1975 Jul;56(1):188-200
references.pmid: 45818
references.citation: Crit Rev Oncol Hematol. 1996 Jan;22(1):1-25
references.pmid: 8672250
references.citation: Eur J Cancer Clin Oncol. 1989 Oct;25(10):1413-7
references.pmid: 2531669
references.citation: J Thromb Haemost. 2010 Sep;8(9):2063-5
references.pmid: 20626619
references.citation: J Thromb Haemost. 2003 Mar;1(3):477-84
references.pmid: 12871453
references.citation: Semin Thromb Hemost. 2004 Oct;30(5):525-35
references.pmid: 15497095
references.citation: Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):E101-6
references.pmid: 11073862
references.citation: Hematology Am Soc Hematol Educ Program. 2012;2012:152-6
references.pmid: 23233574
references.citation: J Thromb Haemost. 2008 Dec;6(12):2062-6
references.pmid: 18983516
references.citation: Blood. 1981 Aug;58(2):326-9
references.pmid: 6788109
references.citation: J Thromb Haemost. 2003 Jul;1(7):1628-36
references.pmid: 12871299
references.citation: Purinergic Signal. 2011 Sep;7(3):333-9
references.pmid: 21484091